Cencora Is Maintained at Buy by UBS
UBS Adjusts Price Target on Cencora to $335 From $298, Maintains Buy Rating
The Price Is Right For Cencora, Inc. (NYSE:COR)
Cencora(COR.US) Officer Sells US$4.11 Million in Common Stock
Cencora Insider Sold Shares Worth $1,437,681, According to a Recent SEC Filing
Express News | Form 144 | Cencora(COR.US) Director Proposes to Sell 4.11 Million in Common Stocks
Citi Maintains Cencora(COR.US) With Buy Rating, Raises Target Price to $330
Here's How Much You Would Have Made Owning Cencora Stock In The Last 10 Years
Express News | Cencora : Citigroup Raises Target Price to $330 From $295
TD Cowen Maintains Cencora(COR.US) With Buy Rating, Raises Target Price to $335
TD Cowen Adjusts Price Target on Cencora to $335 From $288, Keeps Buy Rating
Baird Adjusts Price Target on Cencora to $314 From $308, Keeps Outperform Rating
Analysts Conflicted on These Healthcare Names: Cencora (COR) and Johnson & Johnson (JNJ)
Morgan Stanley Maintains Cencora(COR.US) With Hold Rating, Raises Target Price to $288
Morgan Stanley Adjusts Cencora Price Target to $288 From $263, Maintains Equal Weight Rating
BofA Securities Maintains Cencora(COR.US) With Hold Rating
Bank of America Securities Reaffirms Their Hold Rating on Cencora (COR)
Cencora Is Maintained at Neutral by B of A Securities
Cencora Analyst Ratings
Express News | Cencora : BofA Global Research Raises Price Objective to $285 From $270